{"id":18006,"date":"2021-01-07T13:55:38","date_gmt":"2021-01-07T11:55:38","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=18006"},"modified":"2021-01-07T13:55:38","modified_gmt":"2021-01-07T11:55:38","slug":"is-gamintojo-biontech-pfizer-bus-siekiama-isigyti-daugiau-vakcinu","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/en\/2021\/01\/07\/is-gamintojo-biontech-pfizer-bus-siekiama-isigyti-daugiau-vakcinu\/","title":{"rendered":"I\u0161 gamintojo \u201eBioNTech &#038; Pfizer\u201c bus siekiama \u012fsigyti daugiau vakcin\u0173"},"content":{"rendered":"<p><strong>Vyriausyb\u0117 tre\u010diadien\u012f pritar\u0117 i\u0161ankstin\u0117s pirkimo sutarties su farmacijos kompanija \u201eBioNTech &amp; Pfizer\u201c keitimui, siekiant Lietuvai \u012fsigyti 550 t\u016bkst. papildom\u0173 vakcinos nuo koronaviruso (COVID-19) dozi\u0173.<\/strong><\/p>\n<p>Iki \u0161iol su \u0161iuo gamintoju buvo sutarta d\u0117l kiek daugiau nei 1,8 mln. vakcinos dozi\u0173 Lietuvai. Europos Komisija, vykdydama derybas su gamintojais vis\u0173 Europos S\u0105jungos (ES) valstybi\u0173 vardu, \u0161iuo metu derasi d\u0117l papildom\u0173 vakcinos dozi\u0173.<\/p>\n<p>Lietuva parei\u0161k\u0117 pageidavim\u0105 \u012fsigyti 550 t\u016bkst. papildom\u0173 vakcinos dozi\u0173, ta\u010diau tikslus j\u0173 skai\u010dius paai\u0161k\u0117s tik pasibaigus deryboms.<\/p>\n<p>\u201eBioNTech &amp; Pfizer\u201c sukurta vakcina nuo COVID-19 \u0161iuo metu yra vienintel\u0117, registruota ir naudojama ES. \u012e Lietuv\u0105 jau pristatyta daugiau nei 40 t\u016bkst. \u0161ios vakcinos dozi\u0173, kuriomis pirmi skiepijami \u0161alies medikai.<\/p>\n<p>Lietuva yra sudariusi sutartis su \u0161e\u0161iais vakcin\u0173 gamintojais ir i\u0161 j\u0173 ketina \u012fsigyti daugiau nei 7 mln. vakcinos dozi\u0173. J\u0173 tur\u0117t\u0173 u\u017etekti paskiepyti bent 70 proc. \u0161alies gyventoj\u0173. Pasak specialist\u0173, tokia paskiepyt\u0173 gyventoj\u0173 dalis u\u017etikrint\u0173 kolektyvin\u012f imunitet\u0105 nuo koronaviruso.<\/p>\n<p><em>SAM Spaudos tarnyba<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Vyriausyb\u0117 tre\u010diadien\u012f pritar\u0117 i\u0161ankstin\u0117s pirkimo sutarties su farmacijos kompanija \u201eBioNTech &amp; Pfizer\u201c keitimui, siekiant Lietuvai \u012fsigyti 550 t\u016bkst. papildom\u0173 vakcinos nuo koronaviruso (COVID-19) dozi\u0173. Iki \u0161iol su \u0161iuo gamintoju buvo sutarta d\u0117l kiek daugiau nei 1,8 mln. vakcinos dozi\u0173 Lietuvai. Europos Komisija, vykdydama derybas su gamintojais vis\u0173 Europos S\u0105jungos (ES) valstybi\u0173 vardu, \u0161iuo metu derasi&hellip;<\/p>","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[100],"tags":[],"class_list":["post-18006","post","type-post","status-publish","format-standard","hentry","category-del-covid-19","category-100","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-4Gq","jetpack_featured_media_url":"","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/18006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/comments?post=18006"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/18006\/revisions"}],"predecessor-version":[{"id":18008,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/18006\/revisions\/18008"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media?parent=18006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/categories?post=18006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/tags?post=18006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}